4/A: Viemed Healthcare Executive Reports Stock Transactions Following RSU Vesting

A Viemed Healthcare Vice President of Sales, Jerome Cambre, reported the acquisition of shares through the vesting of restricted stock units and the subsequent withholding of shares for tax obligations.

Summary

• Jerome Cambre, a Vice President of Sales at Viemed Healthcare, filed an amended Form 4 to report changes in beneficial ownership of company stock.
• The changes occurred on January 18, 2025, due to the vesting of restricted stock units (RSUs).
• Mr. Cambre acquired 4,804 common shares through the vesting of RSUs.
• Additionally, 1,713 shares were withheld by the company to cover tax obligations related to the vesting.
• The price per share for the tax withholding was $8.15, based on the market closing price on January 17, 2025.
• Following these transactions, Mr. Cambre beneficially owns 83,034 common shares.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions, which is neither positive nor negative for the company's outlook.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common practice in publicly traded companies. It provides transparency into insider activity and is required by the SEC.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this filing is consistent with those requirements.
• The reporting of RSU vesting and tax withholding is a common occurrence for executives in publicly traded companies.
• The level of detail provided in the filing is consistent with SEC guidelines.

Stakeholder Impact

• The filing provides transparency to shareholders regarding executive stock transactions.
• The transactions have a minor impact on the total number of shares outstanding.

Key Dates

Keywords

Viemed Healthcare, stock transaction, Form 4, restricted stock units, RSU, insider trading, beneficial ownership, executive compensation